David Kemmerly's most recent trade in Amedisys Inc. was a trade of 2,037 Common Stock done at an average price of $177.2 . Disclosure was reported to the exchange on March 29, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amedisys Inc. | David Kemmerly | See Remarks | Sale of securities on an exchange or to another person at price $ 177.21 per share. | 29 Mar 2022 | 2,037 | 16,779 (0%) | 0% | 177.2 | 360,977 | Common Stock |
| Amedisys Inc. | David Kemmerly | See Remarks | Sale of securities on an exchange or to another person at price $ 177.89 per share. | 29 Mar 2022 | 443 | 16,336 (0%) | 0% | 177.9 | 78,805 | Common Stock |
| Amedisys Inc. | David Kemmerly | See Remarks | Sale of securities on an exchange or to another person at price $ 175.15 per share. | 29 Mar 2022 | 20 | 18,816 (0%) | 0% | 175.2 | 3,503 | Common Stock |
| Amedisys Inc. | David Kemmerly | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 3,060 | 3,060 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | David Kemmerly | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 2,618 | 2,618 | - | - | Restricted Share Units (Performance-Based Vesting) | |
| Amedisys Inc. | David Kemmerly | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 1,309 | 19,997 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | David Kemmerly | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.07 per share. | 17 Feb 2022 | 1,161 | 18,836 (0%) | 0% | 141.1 | 163,782 | Common Stock |
| Amedisys Inc. | David Kemmerly | See Remarks | Sale of securities on an exchange or to another person at price $ 290.12 per share. | 27 Apr 2021 | 4,875 | 18,667 (0%) | 0% | 290.1 | 1,414,335 | Common Stock |
| Amedisys Inc. | David Kemmerly | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.35 per share. | 27 Apr 2021 | 3,125 | 23,542 (0%) | 0% | 27.4 | 85,469 | Common Stock |
| Amedisys Inc. | David Kemmerly | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2021 | 3,125 | 0 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | David Kemmerly | See Remarks | Sale of securities on an exchange or to another person at price $ 280.00 per share. | 09 Apr 2021 | 500 | 20,413 (0%) | 0% | 280 | 140,000 | Common Stock |
| Amedisys Inc. | David Kemmerly | See Remarks | Sale of securities on an exchange or to another person at price $ 270.00 per share. | 01 Apr 2021 | 503 | 20,913 (0%) | 0% | 270 | 135,810 | Common Stock |
| Amedisys Inc. | David Kemmerly | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 292.48 per share. | 20 Feb 2021 | 521 | 21,416 (0%) | 0% | 292.5 | 152,382 | Common Stock |
| Amedisys Inc. | David Kemmerly | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 292.48 per share. | 20 Feb 2021 | 131 | 22,021 (0%) | 0% | 292.5 | 38,315 | Common Stock |
| Amedisys Inc. | David Kemmerly | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 292.48 per share. | 20 Feb 2021 | 84 | 21,937 (0%) | 0% | 292.5 | 24,568 | Common Stock |
| Amedisys Inc. | David Kemmerly | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 3,396 | 18,475 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | David Kemmerly | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 3,388 | 22,152 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | David Kemmerly | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 1,698 | 0 | - | - | Restricted Share Units (Performance-Based Vesting) | |
| Amedisys Inc. | David Kemmerly | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 1,600 | 1,600 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | David Kemmerly | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 1,271 | 1,271 | - | - | Restricted Stock Unit (Performance-Based Vesting) | |
| Amedisys Inc. | David Kemmerly | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 636 | 18,764 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | David Kemmerly | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 295.20 per share. | 17 Feb 2021 | 347 | 18,128 (0%) | 0% | 295.2 | 102,434 | Common Stock |